Home ›
Trademark Categories ›
Pharmaceuticals ›
2013 ›
AV ›
AVAXANT
Trademark search for:
AVAXANT
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2013-08-26 — Application filed
2013-09-27 — Sn assigned for sect 66a appl from ib
2013-09-30 — Application filed
2013-10-04 — Application filed
2013-10-09 — Assigned to examiner
2013-10-15 — Suspension letter written
2013-10-16 — Office action issued
2013-10-18 — Office action issued
2013-10-18 — Office action issued
2013-11-14 — Office action issued
2014-05-02 — Assigned to lie
2014-05-05 — Report completed suspension check case still suspended
2014-11-06 — Report completed suspension check case still suspended
2015-03-04 — Notification of possible opposition sent to ib
2015-03-04 — Notification of possible opposition created, to be sent to ib
2015-03-20 — Notification of possible opposition - processed by ib
2015-05-06 — Report completed suspension check case still suspended
2015-07-03 — Change of owner received from ib
2015-11-12 — Report completed suspension check case still suspended
2016-05-20 — Suspension checked - to attorney for action
2016-06-01 — Approved for pub - principal register
2016-06-06 — Law office publication review completed
2016-06-22 — Notice of publication
2016-06-22 — Notification of possible opposition sent to ib
2016-06-22 — Notice of start of opposition period created, to be sent to ib
2016-07-07 — Notification of possible opposition - processed by ib
2016-07-12 — Published for opposition
2016-09-27 — Registered-principal register
2016-12-27 — Final disposition recorded
2016-12-28 — Final disposition recorded
2016-12-28 — Final disposition recorded
2017-01-12 — Final disposition recorded
2023-04-14 — Cancelled section 71
2023-08-25 — Final status recorded
2023-12-14 — Total invalidation of reg ext protection created
2023-12-27 — Total invalidation of reg ext protection sent to ib
2023-12-27 — Invalidation processed
2024-01-12 — Total invalidation processed by the ib
2024-03-24 — Death of international registration
2024-03-24 — Notification of effect of cancellation of intl reg mailed
Owner Information
Glaxosmithkline Biologicals S.A.
BE
Glaxosmithkline Biologicals S.A.
BE
Glaxosmithkline Biologicals S.A.
BE
NOVARTIS AG
CH
Correspondent
Baker & McKenzie Zurich Holbeinstrasse 30 CH-8034 Zürich, SWITZERLAND
Filing Details
Filing Date:
2013-08-26
Status Date:
2023-08-25
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.